MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,497 | +18.3% | 2,403 | +74.0% | 0.00% | – |
| Q2 2023 | $6,339 | -74.8% | 1,381 | -72.8% | 0.00% | – |
| Q1 2023 | $25,156 | -6.7% | 5,082 | +2.9% | 0.00% | – |
| Q4 2022 | $26,972 | -93.6% | 4,940 | -92.4% | 0.00% | – |
| Q3 2022 | $420,000 | +41.9% | 64,644 | +3.4% | 0.00% | – |
| Q2 2022 | $296,000 | -30.0% | 62,528 | +3.3% | 0.00% | – |
| Q1 2022 | $423,000 | – | 60,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |